Yantai Dongcheng Pharmaceutical Group Co.,Ltd. (SHE:002675)

China flag China · Delayed Price · Currency is CNY
13.45
+0.08 (0.60%)
Apr 28, 2026, 3:04 PM CST
Market Cap11.09B -0.9%
Revenue (ttm)2.68B -7.8%
Net Income204.33M +41.7%
EPS0.25 +41.6%
Shares Out824.60M
PE Ratio54.31
Forward PE28.29
Dividend0.08 (0.60%)
Ex-Dividend DateApr 29, 2026
Volume12,963,652
Average Volume30,390,831
Open13.58
Previous Close13.37
Day's Range13.35 - 13.75
52-Week Range12.12 - 18.68
Beta0.01
RSI44.93
Earnings DateApr 28, 2026

About SHE:002675

Yantai Dongcheng Pharmaceutical Group Co.,Ltd. engages in the raw materials, formulations, nuclear medicine, and big health businesses in China and internationally. It operates through API, Formulation, Radio Pharmaceutical, and Others segments. The company offers formulation products, such as powder injections, tablets, capsules, granules, and drop pills for anticoagulation, cardiovascular, anti-tumor, urology, orthopedics, and anti-infection applications. It also provides active pharmaceutical ingredients, including heparin, chondroitin sulfa... [Read more]

Sector Healthcare
Founded 1998
Employees 2,583
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002675
Full Company Profile

Financial Performance

In 2025, SHE:002675's revenue was 2.74 billion, a decrease of -4.46% compared to the previous year's 2.87 billion. Earnings were 195.63 million, an increase of 6.42%.

Financial Statements